Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Royal

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 aloneR S Krouse, R E Royal, G Heywood, et al.
Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.
European Journal of Cancer Care|March 27, 2015
Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedemaK D Cromwell, Y J Chiang, J Armer, et al.
The Cancer Journal From Scientific American|March 1, 1996
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanomaR E Royal, S M Steinberg, R S Krouse, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 aloneR S Krouse, R E Royal, G Heywood, et al.
Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.
European Journal of Cancer Care|March 27, 2015
Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedemaK D Cromwell, Y J Chiang, J Armer, et al.
The Cancer Journal From Scientific American|March 1, 1996
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanomaR E Royal, S M Steinberg, R S Krouse, et al.
Pageof 2